Drug Shortage Report for TEVA-TRYPTOPHAN

Last updated on 2022-05-19 History
Report ID 146098
Drug Identification Number 02240334
Brand name TEVA-TRYPTOPHAN
Common or Proper name TRYPTOPHAN 500MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TRYPTOPHAN
Strength(s) 500MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2021-09-22
Estimated end date 2022-05-20
Actual end date 2022-05-17
Shortage status Resolved
Updated date 2022-05-19
Company comments Item is short-dated and about to expire.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-05-19 French Compare
v13 2022-05-19 English Compare
v12 2022-05-12 French Compare
v11 2022-05-12 English Compare
v10 2022-05-05 French Compare
v9 2022-05-05 English Compare
v8 2022-04-21 French Compare
v7 2022-04-21 English Compare
v6 2022-03-17 French Compare
v5 2022-03-17 English Compare
v4 2021-11-04 French Compare
v3 2021-11-04 English Compare
v2 2021-09-23 French Compare
v1 2021-09-23 English Compare

Showing 1 to 14 of 14